Abt collaborated with the Centers for Disease Control and Prevention to conduct a cross-sectional survey among pregnant women enrolled in a prospective COVID-19 cohort study in Salt Lake City, UT, Birmingham, AL, and New York, NY, from August 9 to December 10, 2020. Upon enrollment, women completed surveys asking about their concerns about COVID-19 illness and the likelihood they would get a COVID-19 vaccine if one were available during pregnancy. Although most pregnant women worried about COVID-19 illness, less than 50 percent were willing to get vaccinated during pregnancy. Non-Hispanic Black and Hispanic women had lower odds of accepting a vaccine compared with non-Hispanic white women. Racial and ethnic disparities in plans to accept COVID-19 vaccine highlight the need to prioritize strategies to address perceived barriers among groups at high risk for COVID-19. Protecting the baby was the most common reason for acceptance and refusal of the COVID-19 vaccine. Patients of minority race and ethnicity and those without prior influenza vaccination were less likely to accept the COVID-19 vaccine.
Learn more about the study: Tracking COVID-19 in Pregnant Women and Infants (ESPI study)